Evidence map›Paper›PMID 40509302›Full record

ArticleMolecules (Basel, Switzerland)2025

Investigation of Mechanochromic and Solvatochromic Luminescence of Cyclometalated Heteroleptic Platinum(II) Complexes with Benzoylthiourea Derivatives.

Monica Iliş, Marilena Ferbinteanu, Cristina Tablet, Viorel Cîrcu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monica IlişDepartment of Inorganic and Organic Chemistry, Biochemistry and Catalysis, University of Bucharest, 4-12 Regina Elisabeta Bld., Sector 5, 030018 Bucharest, Romania.ORCID 0000-0001-5116-4230
Marilena FerbinteanuDepartment of Inorganic and Organic Chemistry, Biochemistry and Catalysis, University of Bucharest, 4-12 Regina Elisabeta Bld., Sector 5, 030018 Bucharest, Romania.ORCID 0000-0002-7019-4635
Cristina TabletFaculty of Pharmacy, Titu Maiorescu University, Gh. Sincai Bd. 16, 040317 Bucharest, Romania.ORCID 0000-0001-6037-2795
Viorel CîrcuDepartment of Inorganic and Organic Chemistry, Biochemistry and Catalysis, University of Bucharest, 4-12 Regina Elisabeta Bld., Sector 5, 030018 Bucharest, Romania.ORCID 0000-0001-9725-9577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two novel cyclometalated platinum(II) complexes based on 2-phenylpyridine (ppy) and 2,4-difluorophenylpyridine (dfppy) ligands in combination with a benzoylthiourea (4-(decyloxy)-N-((4-(decyloxy)phenyl)carbamothioyl)benzamide, BTU) functionalized with decyloxy alkyl chains as auxiliary ligands were synthesized and characterized for their mechanochromic and photophysical properties. Structural characterization was achieved through IR and NMR spectroscopy, single-crystal X-ray diffraction, and TD-DFT calculations. Both complexes exhibit significant photoluminescence with quantum yields up to 28.3% in a 1% PMMA film. The transitions in solution-phase spectra were assigned to mixed metal-to-ligand (MLCT) and intraligand (ILCT) charge-transfer characteristics. Temperature-dependent studies and thermal analyses confirm reversible phase transitions without mesomorphic behavior despite the presence of the two long alkyl chains. Both complexes displayed reversible mechanochromic and solvatochromic luminescence, with a change in emission color from green to red-orange emissions upon grinding and solvent treatment or heating at 80 °C.

Indexed as

benzoylthioureacyclometalationluminescencemechanochromismplatinum(II) complexes

Identifiers

PMID40509302
PMCPMC12156917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.